Nicolas Hohls, 27, was camping in Cape Vidal along the eastern coast with his father, Colin. Colin described the scene in his son's tent after he rushed there in response to Nicolas yelling. "The ...

Sempra Infrastructure Partners has taken final investment decision (FID) to advance development, construction, and operation of Port Arthur LNG Phase 2, under development in Port Arthur, Tex. Port ...

Eli Lilly has pulled the plug on a phase 2b obesity trial before enrolling a single patient, citing “strategic business reasons.” The study was designed to test bimagrumab, an asset Lilly acquired in ...

Mark Zinno has some advice for the NFL after Sunday night's tie between the Green Bay Packers and the Dallas Cowboys: bring back sudden death! More Than 6K Arrested in FL Operation Minnie Driver Slams ...

Antarctica may have passed a climate tipping point of no return, scientists are warning, with mounting evidence that a sudden slump in sea ice formation since 2016 is linked to human-induced ocean ...

This year's Capcom Pro Tour has been riddled with controversies across the board, from auto-qualifying the winning SFL team to the NA casting for Street Fighter 6 in an EU event. It seems that the ...

The North Ridgeville City Schools said that the student tragically passed away after a sudden illness, according to a message to families. CBS affiliate WOIO in Cleveland reports that a crisis ...

SPRINGFIELD, Mo. (KY3) - Phase II of the Kansas Expressway Extension in south Springfield opened on Friday. Greene County leaders say construction was completed on time and under budget. One mile of a ...

Not long after Baylor receiver Kobe Prentice and safety Devyn Bobby got done talking about what they expect as the Bears face Oklahoma State this weekend, the latest coach was axed. After 21 years as ...

The US Food and Drug Administration plans to make changes soon to the lengthy black box warning on many hormone replacement products for women with menopause symptoms, Commissioner Dr. Martin Makary ...

MoonLake Immunotherapeutics’ stock has taken a pummeling after the biotech blamed an unexpectedly high placebo response rate for its much-hyped inflammatory disease prospect missing the key goal of ...